Breaking News

$XXII Movers Alert On 22nd Century Group, Inc. (XXII)




22nd Century is a plant biotechnology company with an important mission: To Reduce the Harm Caused by Smoking.

Our long-term focus is the research, development, licensing, manufacturing, and worldwide sales and distribution of our important products. 22nd Century Group’s proprietary genetic engineering technology and plant breeding expertise allow us to regulate the level of nicotine (and other nicotinic alkaloids) in the tobacco plant. As a result of our unique technology, we are able to grow tobacco with up to 97% less nicotine than conventional tobacco – as well as plants with relatively high nicotine levels. The applications for this technology are extraordinary; in independent clinical studies, our very low nicotine (VLN) tobacco has demonstrated remarkable efficacy as a smoking cessation aid. On the other hand, for smokers who do not wish to quit, our high nicotine tobacco enables us to produce a cigarette with what we believe is the world’s lowest tar-to-nicotine ratio.
We believe that the tobacco industry is at the beginning of a paradigm shift toward the development and commercialization of reduced-risk tobacco products which represent a significant step toward achieving the public health objective of harm reduction. Our 18 years of research and development on the tobacco plant, mainly on the nicotine biosynthetic pathway, uniquely positions us to become a major benefactor of this paradigm shift developing in the tobacco industry. Our technology has created, and will continue to develop, a pipeline of products. We are primarily involved in the following activities:
  • The international licensing of 22nd Century Ltd’s technology, proprietary tobaccos, and trademarks;
  • The research and development of potentially reduced-risk or modified risk tobacco products;
  • The development of X-22, a prescription-based smoking cessation aid consisting of very low nicotine cigarettes;
  • The manufacture, marketing and international distribution of RED SUN and MAGIC proprietary cigarettes;
  • The production of SPECTRUM research cigarettes for the National Institute of Drug Abuse (NIDA); and
  • The contract manufacturing of other companies’ branded tobacco products.

webimage

22nd Century Group is organized around the following wholly-owned operating subsidiaries:

Goodrich Tobacco is focused on commercial tobacco products and potentially less harmful cigarettes.

Botanical Genetics is focused on natural, safe and effective cannabis-based products for human health, well-being and nutrition, in addition to industrial products refined from cannabis.

Heracles Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

NASCO Products is our manufacturing facility located in Mocksville, NC.


22nd Century Launches MAGIC 0 Very Low Nicotine Cigarettes in France
Company Accelerates Rollout of MAGIC Cigarettes Worldwide
22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today the receipt of an initial purchase order for MAGIC 0 Very Low Nicotine cigarettes from French distributor, Royal Distribution. Beginning in June, Royal Distribution will promote and sell the MAGIC brand in France as the world’s lowest nicotine tobacco cigarette. Before the end of 2016, Royal Distribution projects it will have placed MAGIC 0 cigarettes in more than 750 tobacco stores throughout France.
22nd Century is also negotiating with distributors in several additional countries to introduce MAGIC 0 Very Low Nicotine cigarettes broadly to European smokers who wish to reduce their exposure to nicotine. The Company expects to accelerate rollout of MAGIC 0 in Europe and in other markets in the months to come. The American MAGIC website, www.magiccigarettes.com, is available in 8 languages including English, French, Spanish, Italian, Dutch, German, Chinese, and Japanese, and provides details on the science that makes the world’s lowest nicotine cigarettes possible – all without any artificial extraction or chemical processes.
Mr. Mourad Senouci, Director and co-owner of Royal Distribution explained: “MAGIC is different from any other cigarette brand on the French market. Royal Distribution has always been a trendsetter, and this will be also the case with MAGIC. We will focus our marketing on the unique benefits of MAGIC and on its innovative Very Low Nicotine tobacco.”

22nd Century’s MAGIC cigarettes are made with the Company’s proprietary Very Low Nicotine tobacco and are manufactured for sale in Europe on behalf of 22nd Century by Orion Tobacco Corporation. Designed to appeal to discriminating consumers and positioned to compete with premium cigarette brands, MAGIC 0 cigarettes yield only 0.04 mg nicotine per cigarette – 95% less nicotine than conventional cigarette brands. The proprietary tobacco used in MAGIC cigarettes is grown on independently owned farms in the United States and results in an extraordinary cigarette with all of the taste of a conventional cigarette, but with non-addictive levels of nicotine. Unlike conventional cigarettes, MAGIC cigarettes are crafted with a specialty carbon filter which provides full air flow for a smoking experience that smokers describe as “exceptionally smooth and rich.”

“The public health implications of a virtually nicotine-free tobacco cigarette are enormous and 22nd Century is proud to be in a position to bring such an important product to market in France,” explained Henry Sicignano, III, President and Chief Executive Officer of 22nd Century. “Indeed, France is the first of many European countries that will receive MAGIC 0 Very Low Nicotine cigarettes this year; we are now accelerating rollout of this extraordinary product.”

About 22nd Century Group, Inc.

22nd Century is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. Visit www.xxiicentury.com or www.magiccigarettes.com for more information.

Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking information, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of 22nd Century Group, Inc., its directors or its officers with respect to the contents of this press release, including but not limited to our future revenue expectations. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances, or to reflect the occurrence of unanticipated events. You should carefully review and consider the various disclosures made by us in our annual report on Form 10-K for the fiscal year ended December 31, 2015, filed on February 18, 2016, including the section entitled “Risk Factors,” and our other reports filed with the U.S Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

For 22nd Century Group, Inc.:
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com
or
Redington, Inc.
Tom Redington, 203-222-7399

Source: Business Wire (May 25, 2016 - 8:30 AM EDT) 


Tuesday, May 24, 2016

Thursday, May 19, 2016

Tuesday, May 17, 2016

Thursday, May 12, 2016

Tuesday, May 10, 2016

Friday, May 6, 2016

Wednesday, May 4, 2016

Tuesday, May 3, 2016

Monday, May 2, 2016

Monday, April 25, 2016

Monday, April 18, 2016

Thursday, April 14, 2016

Wednesday, April 6, 2016

Thursday, March 31, 2016

Thursday, March 17, 2016

Friday, March 11, 2016

Thursday, March 10, 2016